These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21162613)

  • 1. Adjuvants: no longer a 'dirty little secret', but essential key players in vaccines of the future.
    Arakawa T
    Expert Rev Vaccines; 2011 Jan; 10(1):1-5. PubMed ID: 21162613
    [No Abstract]   [Full Text] [Related]  

  • 2. The 'perfect' adjuvant, a stronger voice.
    Glenn GM
    Expert Rev Vaccines; 2011 Apr; 10(4):399-400. PubMed ID: 21506634
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokines and the mechanisms of action of vaccine adjuvants.
    Brewer JM; Alexander J
    Cytokines Cell Mol Ther; 1997 Dec; 3(4):233-46. PubMed ID: 9740352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity and new adjuvants.
    Mutwiri G; Gerdts V; Lopez M; Babiuk LA
    Rev Sci Tech; 2007 Apr; 26(1):147-56. PubMed ID: 17633299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines and adjuvants--special issue.
    Robinson K; Oyston P
    J Med Microbiol; 2012 Jul; 61(Pt 7):887-888. PubMed ID: 22538995
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccine development: baring the 'dirty little secret'.
    Woodland DL; Blackman MA
    Nat Med; 2005 Jul; 11(7):715-6. PubMed ID: 16015358
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccine adjuvants: scientific challenges and strategic initiatives.
    Harandi AM; Davies G; Olesen OF
    Expert Rev Vaccines; 2009 Mar; 8(3):293-8. PubMed ID: 19249971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New adjuvants for human vaccines.
    Mbow ML; De Gregorio E; Valiante NM; Rappuoli R
    Curr Opin Immunol; 2010 Jun; 22(3):411-6. PubMed ID: 20466528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivalent minigene vaccines against infectious disease.
    An LL; Whitton JL
    Curr Opin Mol Ther; 1999 Feb; 1(1):16-21. PubMed ID: 11249678
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccine adjuvants: a priority for vaccine research.
    Harandi AM; Medaglini D; Shattock RJ;
    Vaccine; 2010 Mar; 28(12):2363-6. PubMed ID: 20064476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in nanoparticle-based vaccination.
    Riedmann EM
    Hum Vaccin Immunother; 2013 Dec; 9(12):2502. PubMed ID: 24716209
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adjuvants in modern medicine and veterinary].
    Kozlov VG; Ozherelkov SV; Sanin AV; Kozhevnikova TN
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):91-101; discussion 101-2. PubMed ID: 24738302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current challenges for vaccine development.
    Oyston P; Robinson K
    J Med Microbiol; 2012 Jul; 61(Pt 7):889-894. PubMed ID: 22322337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving vaccine performance with adjuvants.
    Vogel FR
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S266-70. PubMed ID: 10875797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-genomic challenges for collaborative research in infectious diseases.
    Okeke IN; Wain J
    Nat Rev Microbiol; 2008 Nov; 6(11):858-64. PubMed ID: 18711428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current vaccine updates for lung cancer.
    Simmons O; Magee M; Nemunaitis J
    Expert Rev Vaccines; 2010 Mar; 9(3):323-35. PubMed ID: 20218860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR-7 and -8 agonists as vaccine adjuvants.
    Tomai MA; Vasilakos JP
    Expert Rev Vaccines; 2011 Apr; 10(4):405-7. PubMed ID: 21506636
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adjuvants--essential components of new generation vaccines].
    Dzierzbicka K; Kołodziejczyk AM
    Postepy Biochem; 2006; 52(2):204-11. PubMed ID: 17078510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination adjuvants: the next generation of adjuvants?
    Mutwiri G; Gerdts V; van Drunen Littel-van den Hurk S; Auray G; Eng N; Garlapati S; Babiuk LA; Potter A
    Expert Rev Vaccines; 2011 Jan; 10(1):95-107. PubMed ID: 21162624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine adjuvants: is the pipeline clogged?
    Leitner WW
    Immunotherapy; 2012 Jun; 4(6):565-7. PubMed ID: 22788122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.